REGENERON PHARMACEUTICALS INC. - COMMON STOCK
712.60
05-2月-25 11:38:50
15 分の遅延
株式
+15.55
+2.23%
本日の幅
700.01 - 729.25
ISIN
N/A
ソース
NASDAQ
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
28 2 2024 08:48:56 提供 NetDania Notify
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
26 2 2024 08:48:37 提供 NetDania Notify
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
23 2 2024 08:45:04 提供 NetDania Notify
-
23 2 2024 00:00:00 提供 Nasdaq GlobeNewswire
-
21 2 2024 06:00:13 提供 Nasdaq GlobeNewswire
-
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
15 2 2024 23:59:00 提供 Nasdaq GlobeNewswire
-
Regeneron Announces Investor Conference Presentations
06 2 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
02 2 2024 05:30:01 提供 Nasdaq GlobeNewswire
-
Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
02 2 2024 05:00:04 提供 Nasdaq GlobeNewswire
-
30 1 2024 06:00:41 提供 Nasdaq GlobeNewswire
-
25 1 2024 13:29:00 提供 Nasdaq GlobeNewswire
-
24 1 2024 11:00:00 提供 Nasdaq GlobeNewswire
-
16 1 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
05 1 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
18 12 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Regeneron Named on Dow Jones Sustainability World Index for Fifth Consecutive Year
11 12 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
10 12 2023 18:30:00 提供 Nasdaq GlobeNewswire
-
07 12 2023 06:00:45 提供 Nasdaq GlobeNewswire
-
Regeneron to Share Progress of Novel Combination Therapies in Oncology at ESMO IO
07 12 2023 01:30:59 提供 Nasdaq GlobeNewswire